VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q2 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $7,308,000 | -28.6% | 266,900 | 0.0% | 0.01% | -14.3% |
Q1 2022 | $10,236,000 | +290.7% | 266,900 | +226.3% | 0.01% | +250.0% |
Q4 2021 | $2,620,000 | +8.7% | 81,800 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $2,411,000 | -13.3% | 81,800 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $2,780,000 | -78.5% | 81,800 | -85.4% | 0.00% | -86.7% |
Q1 2020 | $12,939,000 | +76.8% | 561,600 | +124.6% | 0.02% | +114.3% |
Q4 2019 | $7,320,000 | +204.5% | 250,000 | +177.8% | 0.01% | +250.0% |
Q3 2019 | $2,404,000 | +4.5% | 90,000 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $2,300,000 | -28.1% | 90,000 | -40.7% | 0.00% | -50.0% |
Q4 2018 | $3,199,000 | -16.0% | 151,700 | -26.3% | 0.00% | 0.0% |
Q3 2018 | $3,810,000 | +0.1% | 205,700 | +20.5% | 0.00% | 0.0% |
Q2 2018 | $3,808,000 | +1.5% | 170,700 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $3,752,000 | -5.4% | 170,700 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $3,967,000 | +1.2% | 170,700 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $3,919,000 | +21.0% | 170,700 | +16.4% | 0.00% | +33.3% |
Q2 2017 | $3,239,000 | -13.4% | 146,700 | -10.5% | 0.00% | -25.0% |
Q1 2017 | $3,739,000 | +25.8% | 163,900 | +15.3% | 0.00% | +33.3% |
Q4 2016 | $2,973,000 | – | 142,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |